share_log

HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price Target

Benzinga ·  Oct 11, 2023 12:37

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $21 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment